Fintel reports that on January 27, 2025, Morgan Stanley downgraded their outlook for Intellia Therapeutics (NasdaqGM:NTLA) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 449.14% ...
Chinese AI firm DeepSeek has emerged as a potential challenger to U.S. AI companies, demonstrating breakthrough models that ...
A new study has revealed those with cancer experience a shift in values after their diagnosis - now AXA has released a guide ...
It wa a very rough start to New York’s trading week as Nvidia led semiconductor stocks sharply lower, though traders were looking for a buy signal.
Fintel reports that on January 27, 2025, Citigroup upgraded their outlook for SouthState (NYSE:SSB) from Neutral to Buy.